Climara 0.0375mg/day Patches 4s

Manufacturer BAYER Active Ingredient Estradiol Transdermal Weekly Patch(es tra DYE ole) Pronunciation KLY-mah-rah (for brand); es-tra-DYE-ole (for active ingredient)
WARNING: Do not use this drug to prevent heart disease or dementia. A study of women taking an estrogen with a progestin showed a raised chance of heart attack, stroke, blood clot, breast cancer, and dementia. The chance of stroke, blood clot, and dementia was also raised when the estrogen was taken alone. Not all products and doses were studied. It is not known if the same effects may happen with this drug.The chance of endometrial cancer may be raised with the use of estrogen alone in patients with a uterus. Use of a progestin along with estrogen may lower the risk. Call your doctor right away if you have unexplained or long-lasting vaginal bleeding.Use this drug for the shortest time needed at the lowest useful dose. Your doctor will talk with you on a regular basis to see if you need to keep taking this drug. @ COMMON USES: It is used to prevent soft, brittle bones (osteoporosis) after menopause.It is used to prevent or lower the signs of the change of life (menopause).It is used to add estrogen to the body when the ovaries have been taken out or do not work the right way.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Hormone Replacement Therapy (HRT); Estrogen
🧬
Pharmacologic Class
Estrogen receptor agonist
🀰
Pregnancy Category
Category X
βœ…
FDA Approved
Sep 1994
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Climara is a skin patch that contains the hormone estrogen (estradiol). It's used by women after menopause to help relieve symptoms like hot flashes and vaginal dryness, and to prevent bone thinning. You apply one patch to your skin once a week, and it slowly releases estrogen into your body.
πŸ“‹

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. It's essential to use this medication as directed.

Application Instructions

Apply this medication only to your skin, as directed. Do not take it by mouth.
Avoid getting the medication in your mouth, nose, or eyes, as it may cause burning.
Use the medication at the same time every day to maintain a consistent routine.
Before and after applying the medication, wash your hands thoroughly.
Choose a clean, dry, and healthy area of skin on your lower belly or upper buttocks to apply the patch. Rotate the application site with each new patch to avoid skin irritation.
Wait at least 7 days before applying a new patch to the same site.
Do not apply the patch to skin with any problems, such as cuts, wounds, or irritation.
Avoid applying the patch to the breast area.
Do not apply the patch to skin that has been treated with creams, oils, lotions, powder, or other skin products, as this may affect the patch's adhesion.
Choose a hair-free area of skin to apply the patch.
Avoid applying the patch to the waistline or areas that may cause the patch to come off when sitting.
Do not cut or divide the patches, and do not use damaged patches.

Replacing a Patch

If the patch falls off, try to reapply it. If you're unable to reapply the patch, apply a new one to a different area.
Wear only one patch at a time.

Disposing of Used Patches

After removing a used patch, fold the sticky sides together and dispose of it in a secure location where children and pets cannot access it.

Storage and Disposal

Store this medication at room temperature in a dry place, away from bathrooms.
Keep used patches out of reach of children and pets.

Missed Dose

If you miss a dose, apply a new patch as soon as you remember, after removing the old one.
πŸ’‘

Lifestyle & Tips

  • Do not smoke: Smoking significantly increases the risk of blood clots, stroke, and heart attack, especially when taking estrogen.
  • Maintain a healthy weight: Obesity can increase cardiovascular risks.
  • Engage in regular physical activity: Helps maintain bone density and cardiovascular health.
  • Eat a balanced diet: Important for overall health and bone density.
  • Limit alcohol intake: Excessive alcohol can affect liver function and interact with medications.
  • Discuss all medications and supplements with your doctor: Including over-the-counter drugs, herbal remedies, and vitamins, as they can interact with estrogen.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: One Climara 0.0375 mg/day transdermal patch applied topically once weekly. The patch should be worn continuously for 7 days and then replaced with a new patch.
Dose Range: 0.025 - 0.1 mg

Condition-Specific Dosing:

vasomotorSymptoms: Initial dose typically 0.025 mg/day or 0.0375 mg/day, adjusted based on response and tolerability. Lowest effective dose for shortest duration.
vulvarAndVaginalAtrophy: Initial dose typically 0.025 mg/day or 0.0375 mg/day, adjusted based on response and tolerability. Lowest effective dose for shortest duration.
osteoporosisPrevention: 0.025 mg/day or 0.0375 mg/day, if other non-estrogen treatments are not appropriate.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (not indicated for pediatric use)
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended.
Moderate: No specific dose adjustment recommended.
Severe: No specific dose adjustment recommended, but use with caution due to potential fluid retention.
Dialysis: Considerations: Not specifically studied, but caution advised due to potential fluid retention and altered drug metabolism.

Hepatic Impairment:

Mild: No specific dose adjustment recommended.
Moderate: Use with caution; estrogens are extensively metabolized by the liver. Monitor for adverse effects.
Severe: Contraindicated in severe liver disease due to impaired metabolism and increased risk of adverse effects.
Confidence: High

Pharmacology

πŸ”¬

Mechanism of Action

Estradiol is the primary estrogen secreted by the human ovary. It binds to and activates nuclear estrogen receptors (ERΞ± and ERΞ²) in target tissues, forming a complex that interacts with estrogen response elements (EREs) on DNA. This interaction modulates gene transcription, leading to the synthesis of specific proteins responsible for the physiological effects of estrogens, including the development and maintenance of the female reproductive system and secondary sex characteristics. In menopausal women, it replaces declining endogenous estrogen levels to alleviate symptoms like hot flashes and vaginal atrophy, and to prevent bone loss.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 10-20% (transdermal bypasses first-pass hepatic metabolism, leading to a higher systemic bioavailability compared to oral estradiol, but still variable).
Tmax: Approximately 2-4 days after patch application.
FoodEffect: Not applicable for transdermal patch.

Distribution:

Vd: Approximately 1.2 L/kg (for estradiol).
ProteinBinding: Approximately 98% (primarily to sex hormone-binding globulin (SHBG) and albumin).
CnssPenetration: Limited, but estrogens can cross the blood-brain barrier to exert central effects.

Elimination:

HalfLife: Approximately 1-2 hours (for estradiol itself, but sustained release from patch provides continuous delivery).
Clearance: Approximately 650-900 mL/min/mΒ².
ExcretionRoute: Primarily renal (as glucuronide and sulfate conjugates), with some fecal excretion via biliary elimination.
Unchanged: <1% (in urine)
⏱️

Pharmacodynamics

OnsetOfAction: Within days to weeks for symptomatic relief (e.g., hot flashes).
PeakEffect: Steady-state plasma concentrations typically reached within 1-2 weeks of continuous patch application.
DurationOfAction: 7 days (due to continuous release from the weekly patch).

Safety & Warnings

⚠️

BLACK BOX WARNING

Estrogens and progestins should not be used for the prevention of cardiovascular disease or dementia. The Women's Health Initiative (WHI) study reported increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women (50-79 years of age) during 5.6 years of treatment with daily oral conjugated estrogens (0.625 mg) combined with medroxyprogesterone acetate (2.5 mg) relative to placebo. The WHI study also reported an increased risk of stroke and deep vein thrombosis in postmenopausal women (50-79 years of age) during 7.1 years of treatment with daily oral conjugated estrogens (0.625 mg) alone relative to placebo. The WHI Memory Study (WHIMS), an ancillary study of WHI, reported an increased risk of probable dementia in postmenopausal women 65 years of age or older during 4 years of treatment with daily oral conjugated estrogens plus medroxyprogesterone acetate and in postmenopausal women 65 years of age or older during 5.2 years of treatment with daily oral conjugated estrogens alone relative to placebo. These risks apply to all estrogen-containing products.
⚠️

Side Effects

Serious Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of gallbladder problems, such as:
+ Pain in the upper right belly area, right shoulder area, or between the shoulder blades
+ Yellow skin or eyes
+ Fever with chills
+ Bloating
+ Severe upset stomach or vomiting
Signs of pancreatitis (pancreas problem), including:
+ Severe stomach pain
+ Severe back pain
+ Severe upset stomach or vomiting
Signs of high blood pressure, such as:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Weakness on one side of the body
Trouble speaking or thinking
Changes in balance
Drooping on one side of the face
Blurred eyesight
Eyesight changes or loss
Bulging eyes
Changes in how contact lenses feel
Breast lump, pain, or soreness
Nipple discharge
Vaginal itching or discharge
Abnormal vaginal bleeding
Depression or mood changes
Memory problems or loss
Fever
Difficulty urinating or changes in urine output
Pain while urinating

This medication may cause fluid retention, leading to swelling or weight gain. If you experience any of these symptoms, inform your doctor.

Blood Clots and High Calcium Levels

Seek immediate medical attention if you experience:

Signs of a blood clot, such as:
+ Chest pain or pressure
+ Coughing up blood
+ Shortness of breath
+ Swelling, warmth, numbness, changes in color, or pain in a leg or arm
+ Trouble speaking or swallowing
Signs of high calcium levels, including:
+ Weakness
+ Confusion
+ Fatigue
+ Headache
+ Upset stomach or vomiting
+ Constipation
+ Bone pain

Other Side Effects

Most people do not experience severe side effects, but some may occur. If you notice any of the following side effects, contact your doctor or seek medical help if they bother you or do not go away:

Dizziness or headache
Hair loss
Upset stomach or vomiting
Constipation
Stomach pain or cramps
Bloating
Enlarged or tender breasts
Vaginal bleeding or spotting
Painful periods
Common cold symptoms
Nose or throat irritation
Weight gain or loss
Joint pain
Leg cramps
Changes in sex interest
Irritation at the injection site

Reporting Side Effects

If you have questions about side effects or experience any unusual symptoms, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Sudden severe headache or migraines
  • Sudden vision changes (e.g., partial or complete loss of vision, double vision)
  • Sudden numbness or weakness on one side of the body
  • Slurred speech or difficulty speaking
  • Sudden chest pain, shortness of breath, or coughing up blood
  • Pain, swelling, or tenderness in one or both legs (especially calf or thigh)
  • Yellowing of the skin or eyes (jaundice)
  • Severe abdominal pain
  • New breast lump or changes in existing breast lumps
  • Unusual or abnormal vaginal bleeding after menopause
  • Severe mood changes or depression
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
A history of certain health conditions, such as:
+ Bleeding disorders
+ Blood clots or an increased risk of blood clots
+ Breast cancer
+ Liver problems or liver tumors
+ Heart attack
+ Stroke
+ Tumors that are estrogen-dependent
Unexplained vaginal bleeding
Pregnancy or potential pregnancy. Note: This medication is contraindicated during pregnancy and should not be taken if you are pregnant.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine the safety of taking this medication in conjunction with your other treatments and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Your doctor may advise you to stop taking this drug before certain surgical procedures, and if so, will instruct you on when to resume taking it after the surgery or procedure.

If you anticipate being immobile for extended periods, such as during long trips, bedrest after surgery, or illness, discuss this with your doctor, as prolonged immobility may increase your risk of developing blood clots. If you have diabetes, it is crucial to closely monitor your blood sugar levels.

Be aware that medications like this one can cause high blood pressure. Follow your doctor's instructions for regular blood pressure checks. Additionally, have your blood work and bone density checked as directed by your doctor.

Regular breast exams and gynecology check-ups are vital, and you should also perform breast self-exams as instructed by your doctor. The risk of certain side effects, such as heart attack, stroke, breast cancer, ovarian cancer, and others, may vary depending on factors like the duration of estrogen use, whether it is taken with or without a progestin, and other individual factors. Discuss the benefits and risks of using this medication with your doctor.

High triglyceride levels have been associated with this drug. If you have a history of high triglyceride levels, inform your doctor. This medication may cause dark skin patches on your face, so it is essential to avoid sun exposure, sunlamps, and tanning beds, and to use sunscreen and protective clothing and eyewear when outdoors.

This drug may interfere with certain laboratory tests, so be sure to inform all your healthcare providers and lab personnel that you are taking this medication. Avoid smoking, as it increases the risk of heart disease, and limit your alcohol consumption. If you regularly consume grapefruit juice or eat grapefruit, discuss this with your doctor.

For optimal effectiveness, use this medication in conjunction with calcium and vitamin D supplements and engage in weight-bearing exercises, such as walking or physical therapy, as directed by your doctor. Follow the diet and exercise plan recommended by your doctor.

In some cases, this medication may affect growth in children and teenagers, so regular growth checks may be necessary. Discuss this with your doctor. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. If you are breastfeeding, consult with your doctor to discuss any potential risks to your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Nausea
  • Vomiting
  • Breast tenderness
  • Abdominal pain
  • Drowsiness/fatigue
  • Withdrawal bleeding (in females)

What to Do:

There is no specific antidote for estrogen overdose. Treatment is symptomatic and supportive. Remove the patch immediately. In case of suspected overdose, contact a poison control center (1-800-222-1222) or seek emergency medical attention.

Drug Interactions

🚫

Contraindicated Interactions

  • Aromatase inhibitors (e.g., anastrozole, letrozole, exemestane) - concurrent use may reduce efficacy of aromatase inhibitors.
  • Tranexamic acid (increased risk of thrombosis).
πŸ”΄

Major Interactions

  • CYP3A4 inducers (e.g., rifampin, carbamazepine, phenobarbital, phenytoin, St. John's Wort) - may decrease estradiol levels, reducing efficacy.
  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin, ritonavir) - may increase estradiol levels, increasing risk of adverse effects.
  • Thyroid hormone replacement therapy (e.g., levothyroxine) - estrogens can increase thyroid-binding globulin (TBG), potentially increasing thyroid hormone requirements.
  • Corticosteroids (e.g., prednisone) - estrogens may decrease the clearance of corticosteroids, leading to increased effects.
  • Warfarin - estrogens may alter the anticoagulant effect of warfarin; monitor INR closely.
🟑

Moderate Interactions

  • Grapefruit juice (oral estrogens, less relevant for transdermal but caution advised).
  • Fluvoxamine (potential increase in estrogen levels).
  • Lamotrigine (estrogens may decrease lamotrigine levels, leading to loss of seizure control).
🟒

Minor Interactions

  • Not specifically identified for transdermal estradiol in a clinically significant minor category.

Monitoring

πŸ”¬

Baseline Monitoring

Complete medical history and physical examination

Rationale: To identify contraindications, risk factors (e.g., cardiovascular disease, breast cancer, liver disease), and establish baseline health status.

Timing: Prior to initiation of therapy.

Blood pressure

Rationale: Estrogens can cause fluid retention and may affect blood pressure.

Timing: Prior to initiation of therapy.

Breast examination and mammography

Rationale: To screen for pre-existing breast conditions and establish baseline for breast health monitoring.

Timing: Prior to initiation of therapy, as appropriate for age and risk factors.

Pelvic examination and Pap test

Rationale: To screen for gynecological conditions and establish baseline for reproductive health monitoring.

Timing: Prior to initiation of therapy, as appropriate for age and risk factors.

Lipid profile (total cholesterol, HDL, LDL, triglycerides)

Rationale: Estrogens can affect lipid metabolism; establish baseline for cardiovascular risk assessment.

Timing: Prior to initiation of therapy.

Liver function tests (ALT, AST, bilirubin)

Rationale: Estrogens are metabolized by the liver; assess hepatic function, especially if history of liver disease.

Timing: Prior to initiation of therapy, if clinically indicated.

πŸ“Š

Routine Monitoring

Annual physical examination (including blood pressure, breast and pelvic exams)

Frequency: Annually

Target: Normal for age and individual

Action Threshold: Significant changes or abnormalities require further investigation.

Mammography

Frequency: Periodically, as recommended by guidelines (e.g., every 1-2 years)

Target: No suspicious findings

Action Threshold: New lumps, pain, or suspicious findings require immediate follow-up.

Blood pressure

Frequency: Annually, or more frequently if clinically indicated

Target: <130/80 mmHg (general target)

Action Threshold: Sustained elevation (e.g., >140/90 mmHg) may require dose adjustment or discontinuation.

Assessment of symptoms and tolerability

Frequency: At least annually, or as needed

Target: Symptom relief with minimal adverse effects

Action Threshold: Persistent symptoms, intolerable side effects, or new concerns warrant re-evaluation of therapy.

πŸ‘οΈ

Symptom Monitoring

  • Signs of thromboembolic events (e.g., sudden chest pain, shortness of breath, severe headache, sudden vision changes, pain/swelling in leg)
  • Signs of myocardial infarction (e.g., chest pain, discomfort in other areas of upper body, shortness of breath, cold sweat, nausea, lightheadedness)
  • Signs of stroke (e.g., sudden numbness or weakness, confusion, trouble speaking, trouble seeing, sudden severe headache, trouble walking)
  • Abnormal vaginal bleeding (e.g., postmenopausal bleeding, irregular bleeding)
  • Breast lumps or changes
  • Jaundice or signs of liver dysfunction (e.g., dark urine, pale stools, persistent nausea/vomiting)
  • Severe abdominal pain
  • Mood changes or depression

Special Patient Groups

🀰

Pregnancy

Contraindicated in pregnancy. Estrogens are not indicated for use in pregnant women. There is no indication for estrogen therapy during pregnancy, and there is evidence of potential harm to the fetus (e.g., feminization of male fetuses, congenital anomalies).

Trimester-Specific Risks:

First Trimester: Potential for feminization of male fetuses and other congenital anomalies.
Second Trimester: Not applicable, contraindicated.
Third Trimester: Not applicable, contraindicated.
🀱

Lactation

Not recommended during lactation. Estrogens are known to be excreted in human milk and can reduce the quantity and quality of breast milk. Potential adverse effects on the nursing infant have not been fully established but are a concern.

Infant Risk: Moderate to High (L4) - Potential for decreased milk production and excretion into breast milk. Consider alternative methods of contraception if needed, and non-hormonal options for menopausal symptoms if breastfeeding.
πŸ‘Ά

Pediatric Use

Not indicated for use in pediatric patients. Safety and efficacy have not been established in this population. Estrogen therapy in children could affect bone maturation and sexual development.

πŸ‘΄

Geriatric Use

Use with caution, especially in women 65 years of age or older. The WHIMS study showed an increased risk of probable dementia in women 65 years of age or older receiving estrogen alone or estrogen plus progestin. The lowest effective dose for the shortest duration should be used. Increased risk of stroke and venous thromboembolism may also be present in older women.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Transdermal estradiol bypasses first-pass hepatic metabolism, resulting in a more favorable estrogen-to-estrone ratio and potentially fewer hepatic effects (e.g., on clotting factors, triglycerides) compared to oral estrogens.
  • The patch should be applied to a clean, dry area of the trunk (e.g., lower abdomen, buttocks) and rotated to avoid irritation. Avoid applying to breasts or waistline.
  • Adherence is crucial for efficacy; patients should be instructed on proper application and weekly replacement.
  • For women with an intact uterus, a progestin must be co-administered to reduce the risk of endometrial hyperplasia and cancer.
  • Regular re-evaluation (at least annually) of the need for continued therapy is essential, using the lowest effective dose for the shortest duration consistent with treatment goals and risks.
  • Patients should be educated on the signs and symptoms of serious adverse events (e.g., blood clots, stroke, heart attack, breast cancer) and instructed to seek immediate medical attention if they occur.
πŸ”„

Alternative Therapies

  • Other transdermal estradiol formulations (e.g., gels, sprays)
  • Oral estrogens (e.g., conjugated estrogens, oral estradiol)
  • Vaginal estrogens (e.g., creams, rings, tablets) for localized symptoms
  • Selective Estrogen Receptor Modulators (SERMs) (e.g., ospemifene, bazedoxifene/conjugated estrogens)
  • Non-hormonal therapies for vasomotor symptoms (e.g., SSRIs/SNRIs like paroxetine, venlafaxine; gabapentin; clonidine)
  • Bisphosphonates, denosumab, teriparatide for osteoporosis prevention/treatment (if estrogen is contraindicated or not preferred for bone health)
πŸ’°

Cost & Coverage

Average Cost: $150 - $300 per 4 patches (1 month supply)
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (for brand-name); Tier 1 (for generic)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more details. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide information about the medication taken, the amount, and the time it happened.